Trial reportBMC ophthalmology2024
An exploration of safe and efficient nucleus fragmentation strategies for femtosecond laser-assisted cataract surgery in short axial length patients.
Trial report in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Efficacy and safety analysis of LenSX and Catalys femtosecond laser systems in short axial length patients.Lasers in medical science · 2026Trial
- Neurotrophic effects of topical insulin in persistent epithelial defects.International ophthalmology · 2026Article
- Clinical outcomes of the eight-chop technique in white cataract: a retrospective case series.BMC ophthalmology · 2026Observational
- Investigation into the influence of secondary suction within FLACS on the postoperative ocular surface and associated mechanisms.Journal of cataract and refractive surgery · 2026Article
- Greening vision: balancing clinical excellence and ecological sustainability in eye health.Frontiers in public health · 2025Review
- Intravitreal drug injection for glaucoma: mechanisms, clinical efficacy, and future horizons.Frontiers in pharmacology · 2025Review
- "Spider Web"-like zonular deposits in pseudoexfoliation syndrome: endoscopic insights-a case report.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
pureposeThe intraoperative femtosecond laser time, Cumulative Dissipated Energy (CDE), Effective Phacoemulsification time (EPT), and intraoperative fluid perfusion volume were compared under different model fragmentation modes using Catalys femtosecond laser system.
methodsThis was a single-center, prospective, randomized controlled study. A total of 120 eyes who underwent femtosecond laser-assisted cataract phacoemulsification combined with intraocular lens implantation in Xiamen Eye Center affiliated to Xiamen University from September 2022 to March 2023 were randomly divided into 4 groups to undergo pre-nucleus splitting in different ways: Group 1: six-split, Group 2: eight-split, Group 3: six-split + gridded softening, and Group 4: eight-split + gridded softening. Patient age, gender, LOCS III grade, intraoperative femtosecond laser time, CDE, EPT, and intraoperative fluid perfusion volume were collected and analyzed.
resultResult SNK test and Bonferroni test showed no significant difference in the nuclear hardness of lens, age, gender, AL, ACD, WTW and LT among the four groups (P > 0.05). Femtosecond laser time: Group 1: 44.87 ± 21.08s; Group 2: 43.10 ± 16.57s; Group 3: 50.70 ± 17.30s; Group 4: 64.04 ± 30.08s. There was no significantly different among groups 1, 2 and 3 (P > 0.05). However, the difference between group 4 and Group 1&2 was statistically significant (P
conclusionsShort axial length patients may benefit more from the Catalys femtosecond laser system's six or eight-split nucleus mode Settings, which produce the same or even more effective pre-split treatment than the mesh softening mode while using less femtosecond laser time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.